Biostent catheter-delivered drug that blocks vascular remodeling: Began Phase I trial of four dose levels in 46 patients

NeoRx Corp. (NERX), Seattle Product: Biostent catheter-delivered drug that blocks vascular remodeling Indication: Prevent reclosure of arteries opened by balloon angioplasty Status: Began Phase I tria...